Eltahan, Naglaa Hamdi
Elsawy, Neamat Hamdy
Abdelaaty, Kholoud M.
Elhamaky, Amal Salah
Hassan, Ahmed H.
Emara, Moataz Maher
Funding for this research was provided by:
Mansoura University
Article History
Received: 6 September 2023
Accepted: 13 February 2024
First Online: 22 February 2024
Declarations
:
: On June 2nd, 2021, we received IRB approval (No. R.21.04.1300) at Mansoura University, Faculty of Medicine. Written informed consent was obtained from the patient or, if the patient was unable to provide consent, from the legal representative. One of the investigators signed two copies of the consent form with the patient or legal representative (one for the investigator and one for the patient). Both the conducting investigator and the patient signed and dated the consent form. Patients or their legal representatives (in the case of unconscious patients) were clearly informed that all patients have equal chances of receiving active treatment or placebo.
: All patients have signed a consent for publication (item 10 in the consent) of anonymized clinical data. The consent form is available as a supplement to the published protocol [CitationRef removed].
: All authors report no financial or other competing interests.